Update regarding the approval process of Actiste Mini in UAE

The market approval process for Actiste Mini as a medical device in the United Arab Emirates is, as previously stated, underway. Step one out of three has been completed (the three steps being 1. Classification stage, 2. Product registration stage, and 3. Manufacturing stage). Brighter will commence the second step shortly. Since the manufacturing phase has already been completed during the Actiste registration earlier, Actiste Mini will hopefully be granted registration in the country shortly after completion of the second step of the process.

For further information, please contact:

Investor Relations
IR@brighter.se

Christer Trägårdh, Acting CEO
christer.tragardh@brighter.se

Certified Adviser
Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 10, adviser@eminova.se, www.eminova.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.